314 related articles for article (PubMed ID: 21795396)
1. S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells.
Sack U; Walther W; Scudiero D; Selby M; Aumann J; Lemos C; Fichtner I; Schlag PM; Shoemaker RH; Stein U
Mol Biol Cell; 2011 Sep; 22(18):3344-54. PubMed ID: 21795396
[TBL] [Abstract][Full Text] [Related]
2. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
[TBL] [Abstract][Full Text] [Related]
3. Intervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis.
Stein U; Arlt F; Smith J; Sack U; Herrmann P; Walther W; Lemm M; Fichtner I; Shoemaker RH; Schlag PM
Neoplasia; 2011 Feb; 13(2):131-44. PubMed ID: 21403839
[TBL] [Abstract][Full Text] [Related]
4. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.
Stein U; Arlt F; Walther W; Smith J; Waldman T; Harris ED; Mertins SD; Heizmann CW; Allard D; Birchmeier W; Schlag PM; Shoemaker RH
Gastroenterology; 2006 Nov; 131(5):1486-500. PubMed ID: 17101323
[TBL] [Abstract][Full Text] [Related]
5. Wnt up your mind - intervention strategies for S100A4-induced metastasis in colon cancer.
Sack U; Stein U
Gen Physiol Biophys; 2009; 28 Spec No Focus():F55-64. PubMed ID: 20093727
[TBL] [Abstract][Full Text] [Related]
6. Niclosamide: an established antihelminthic drug as a potential therapy against S100A4-mediated metastatic colon tumors.
Helfman DM
J Natl Cancer Inst; 2011 Jul; 103(13):991-2. PubMed ID: 21685360
[No Abstract] [Full Text] [Related]
7. Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation.
Dahlmann M; Sack U; Herrmann P; Lemm M; Fichtner I; Schlag PM; Stein U
Oncotarget; 2012 Aug; 3(8):783-97. PubMed ID: 22878175
[TBL] [Abstract][Full Text] [Related]
8. Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt/β-Catenin Signaling Pathway and EMT.
Wang J; Cai H; Liu Q; Xia Y; Xing L; Zuo Q; Zhang Y; Chen C; Xu K; Yin P; Chen T
Am J Chin Med; 2020; 48(3):703-718. PubMed ID: 32329642
[TBL] [Abstract][Full Text] [Related]
9. C644-0303, a small-molecule inhibitor of the Wnt/β-catenin pathway, suppresses colorectal cancer growth.
Yan Y; Zhang Y; Li M; Zhang Y; Zhang X; Zhang X; Xu Y; Wei W; Wang J; Xu X; Song Q; Zhao C
Cancer Sci; 2021 Nov; 112(11):4722-4735. PubMed ID: 34431598
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of S100A4 in human cancer cell lines resistant to methotrexate.
Mencía N; Selga E; Rico I; de Almagro MC; Villalobos X; Ramirez S; Adan J; Hernández JL; Noé V; Ciudad CJ
BMC Cancer; 2010 Jun; 10():250. PubMed ID: 20515499
[TBL] [Abstract][Full Text] [Related]
11. S100A4 negatively regulates β-catenin by inducing the Egr-1-PTEN-Akt-GSK3β degradation pathway.
Yang W; Nam K; Ju JH; Lee KM; Oh S; Shin I
Cell Signal; 2014 Oct; 26(10):2096-106. PubMed ID: 24975844
[TBL] [Abstract][Full Text] [Related]
12. Selective Wnt/β-catenin Small-molecule Inhibitor CWP232228 Impairs Tumor Growth of Colon Cancer.
Kim JY; Park G; Krishnan M; Ha E; Chun KS
Anticancer Res; 2019 Jul; 39(7):3661-3667. PubMed ID: 31262892
[TBL] [Abstract][Full Text] [Related]
13. Emodin Inhibits Colon Cancer Cell Invasion and Migration by Suppressing Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Pathway.
Gu J; Cui CF; Yang L; Wang L; Jiang XH
Oncol Res; 2019 Feb; 27(2):193-202. PubMed ID: 29301594
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-27a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP1 through the Wnt/β-Catenin Signaling Pathway.
Ba S; Xuan Y; Long ZW; Chen HY; Zheng SS
Cell Physiol Biochem; 2017; 42(5):1920-1933. PubMed ID: 28772260
[TBL] [Abstract][Full Text] [Related]
15. The impact of pyrvinium pamoate on colon cancer cell viability.
Wiegering A; Uthe FW; Hüttenrauch M; Mühling B; Linnebacher M; Krummenast F; Germer CT; Thalheimer A; Otto C
Int J Colorectal Dis; 2014 Oct; 29(10):1189-98. PubMed ID: 25060218
[TBL] [Abstract][Full Text] [Related]
16. Tumor Suppressive Role of ARHGAP17 in Colon Cancer Through Wnt/β-Catenin Signaling.
Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
Cell Physiol Biochem; 2018; 46(5):2138-2148. PubMed ID: 29730655
[TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging.
Yeh CT; Rao YK; Ye M; Wu WS; Chang TC; Wang LS; Wu CH; Wu AT; Tzeng YM
Toxicol Appl Pharmacol; 2012 May; 261(1):31-41. PubMed ID: 22465936
[TBL] [Abstract][Full Text] [Related]
18. Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/β-catenin signaling.
Wu K; Yang Q; Mu Y; Zhou L; Liu Y; Zhou Q; He B
Int J Oncol; 2012 Jul; 41(1):292-8. PubMed ID: 22469784
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of 2-hydroxycinnamaldehyde for human colon cancer cells through suppression of β-catenin signaling.
Lee MA; Park HJ; Chung HJ; Kim WK; Lee SK
J Nat Prod; 2013 Jul; 76(7):1278-84. PubMed ID: 23855266
[TBL] [Abstract][Full Text] [Related]
20. ACBP suppresses the proliferation, migration, and invasion of colorectal cancer via targeting Wnt/beta-catenin signaling pathway.
Tong X; Zhuang Z; Wang X; Yang X; Bai L; Su L; Wei P; Su X
Biomed Pharmacother; 2021 May; 137():111209. PubMed ID: 33581651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]